- John P. Roberts, M.D.
- Nancy L. Ascher, M.D., Ph.D.
- Lee Ann Baxter-Lowe, Ph.D.
- Todd Brennan, M.D., M.S.
- Sandy Feng, M.D., Ph.D.
- Chris E. Freise, M.D.
- Ryutaro Hirose, M.D.
- Sang-Mo Kang, M.D.
- Matthew H. Levine, M.D., Ph.D.
- Andrew M. Posselt, M.D., Ph.D.
- Kayvan Roayaie, M.D.
- Peter G. Stock, M.D., Ph.D.
- Qizhi Tang, Ph.D.
- Holger Willenbring, M.D.
Find a Program
Find a Lab
MESSAGE FROM THE CHIEF
John P. Roberts, M.D.
Professor & Chief,
Division of Transplant Surgery
Sang-Mo Kang, M.D.
Assistant Professor of Surgery
Contact Information
(415) 353-1888 Clinical, Liver
(415) 353-1551 Clinical, Kidney and Pancreas
(415) 476-0789 Academic
kangs@surgery.ucsf.edu
Education
- Cornell University, B.A., Chemistry, with Distinction, 1982-86
- Harvard Medical School, Boston, MA, M.D., 1986-92
Residencies
- University of California, San Francisco, Intern and Resident, General Surgery Program, 1992-95
- University of California, San Francisco, Resident, General Surgery Program, 1997-99
Fellowships
- University of California, San Francisco, Fellow, Transplant Surgery, 1999-01
Postdoctoral Training
- University of California, San Francisco, Postdoctoral Fellow , Immunology and Transplantation, 1995-97
Board Certification
- American Board of Surgery, 2000
Clinical Expertise
- Liver Transplantation
- Kidney Transplantation,
- Intestinal Transplantation and Rehabilitation
- Pancreas Transplantation
- Laparoscopic Donor Nephrectomy
- Choledochal Cyst Disease in Adults
Research Interests
- Transplant Immunology
- Dendritic Cell Immune Therapy
- Novel Strategies for the Induction of Transplant-specific Tolerance
- T-cell Mediated Transplant Rejection as well as Tolerance
-
Biography
Dr. Kang received his B.S. in chemistry from Cornell University and then his M.D. from Harvard University Medical School. He completed a general surgery residency, and immunology and clinical transplantation fellowships at University of California, San Francisco. Dr Kang was recognized with two Howard Hughes Medical Institute Fellowships, one during medical school and one during his residency. He is certified by the American Board of Surgery. Dr. Kang joined the UCSF faculty in 2001 as an Assistant Professor. Since 2005 he has also been the Surgical Director of Small Bowel Transplantation. Along with his roles at UCSF, Dr. Kang is a member of numerous medical societies such as the American Society of Transplant Surgeons, American College of Surgeons, American Association of Immunologists, National Kidney Foundation, Association for Academic Surgery, and Society of University Surgeons. In addition to his clinical role, Dr. Kang conducts various clinical and animal research projects, although his focus is in the development of novel strategies for the induction of transplant-specific tolerance. During his active research he has published dozens of articles in medical and scientific journals and has been invited to present at many national and international seminars and conferences.Selected Publications
- Kang SM, Braat D, Schneider DB, O'Rourke RW, Lin Z, Ascher NL, Dichek DA, Baekkeskov S, Stock PG. A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants. Transplantation. 69: 1813-7, May/15/2000.
- Garrod KR, Chang CK, Liu F-C, Brennan TV, Foster RD, Kang S-M. Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival. Journal of Immunology. 06/2006.
- Kang SM, Tang Q, Bluestone JA. CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects. Am J Transplant. 7: 1457-63, Jun/2007.
- Kim J, Chang CK, Hayden T, Liu F-C, Benjamin J, Hamerman JA, Lanier LL, Kang S-M. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. Journal of Immunology. 179: 6405-6410, 11/15/2007.
- Brennan TV, Hoang V, Garrod K, Liu F-C, Hayden T, Kim J, Kang S-M. A new TCR transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection. Transplantation. 12/11/2007.